1. Committee for Medicinal Products for Human Use (2007) Guideline on the limits of genotoxic impurities. Committee for Medicinal Products for Human Use, European Medicines Agency
2. Food and Drug Administration (2008) Guidance for industry: Genotoxic and carcinogenic impurities in APIs and products, recommended approaches. Food and Drug Administration, U.S. Department of Health and Human Services: Center for Drug Evaluation and Research (CDER)
3. ICH Q3A (R) Impurities in new APIs (R2) (2006) International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use
4. ICH Q3B (R2) Impurities in New Drug Products (2006) International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use
5. Dobo KL, Greene N, Cyr MO, Caron S, Ku WW (2006) Reg Toxicol Pharma 44:282–293